Evidence map›Paper›PMID 41402807›Full record

ArticleRespiratory research2025

DNMT1 deficiency promotes pulmonary vascular remodeling in pulmonary hypertension through epigenetic upregulation of BMP7.

Yong-Bing Wang, Lei Gao, Jia-Xin Wang, Zhe Mei, You-Li Fan, Xuan Gao, Jing Huang, Bin-Feng Sun, Yu-Fei Gao, Na Sun and 2 more

Abstract read
In one paragraph

Article in Respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yong-Bing WangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, and The Key Laboratory of Myocardial Ischemia, Ministry of Education, No. 246 Xuefu Road, 150086, Harbin, China.
Lei GaoDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, and The Key Laboratory of Myocardial Ischemia, Ministry of Education, No. 246 Xuefu Road, 150086, Harbin, China.
Jia-Xin WangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, and The Key Laboratory of Myocardial Ischemia, Ministry of Education, No. 246 Xuefu Road, 150086, Harbin, China.
Zhe MeiDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, and The Key Laboratory of Myocardial Ischemia, Ministry of Education, No. 246 Xuefu Road, 150086, Harbin, China.
You-Li FanDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, and The Key Laboratory of Myocardial Ischemia, Ministry of Education, No. 246 Xuefu Road, 150086, Harbin, China.
Xuan GaoDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, and The Key Laboratory of Myocardial Ischemia, Ministry of Education, No. 246 Xuefu Road, 150086, Harbin, China.
Jing HuangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, and The Key Laboratory of Myocardial Ischemia, Ministry of Education, No. 246 Xuefu Road, 150086, Harbin, China.
Bin-Feng SunDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, and The Key Laboratory of Myocardial Ischemia, Ministry of Education, No. 246 Xuefu Road, 150086, Harbin, China.
Yu-Fei GaoDepartment of Emergency, Heilongjiang Provincial Hospital, Harbin, China.
Na SunDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, and The Key Laboratory of Myocardial Ischemia, Ministry of Education, No. 246 Xuefu Road, 150086, Harbin, China. sunna@hrbmu.edu.cn.
Xiao-Dong ZhengDepartment of Medical Genetics, Harbin Medical University-Daqing, and Engineering Technology Research Center for Precision Diagnosis and Treatment of Frigid Zone-Related Diseases in Heilongjiang Province, No. 39 Xinyang Road, Gaoxin District, 163319, Daqing, China. zhengxiaodong@hmudq.edu.cn.
Bing-Xiang WuDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, and The Key Laboratory of Myocardial Ischemia, Ministry of Education, No. 246 Xuefu Road, 150086, Harbin, China. wubingxiang1964@163.com.

Funding

National Key Research and Development Program of China 2022YFC2703900National Natural Science Foundation of China 82270049National Natural Science Foundation of China 82300070
6 · The paper itself

Abstract

backgroundPulmonary hypertension (PH) is a progressive cardiopulmonary disorder marked by pathological vascular remodeling, predominantly driven by the hyperproliferation of pulmonary artery smooth muscle cells (PASMCs). Although bone morphogenetic protein 7 (BMP7) has been implicated in PASMCs dysregulation, the precise upstream mechanisms governing its expression in PH remain elusive.

methodsIn vitro and in vivo models of hypoxia-induced PH were employed. The mRNA and protein levels of the different molecules were quantified using qRT-PCR and Western blot. The role of BMP7 in PASMCs proliferation, cell cycle progression and apoptosis were assessed using Cell Counting Kit-8 (CCK-8) assays, Western blotting, immunofluorescence, and flow cytometry. Moreover, the epigenetic regulatory mechanisms of BMP7 were elucidated using Chromatin immunoprecipitation-quantitative PCR (ChIP-qPCR) and quantitative methylation-specific PCR (qMSP). In vivo functional roles of BMP7 were validated using recombinant protein administration and AAV5-mediated gene knockdown in hypoxic mice, with evaluations of hemodynamics, echocardiography, and vascular remodeling.

resultsHypoxia significantly upregulated BMP7 expression in PASMCs and lung tissues of PH models. Exogenous BMP7 enhanced PASMCs proliferation, accelerated cell cycle progression and suppressed apoptosis. Conversely, BMP7 knockdown attenuated these pro-proliferative and anti-apoptotic responses. Mechanistically, DNMT1 was downregulated under hypoxia, and its genetic or pharmacological inhibition elevated BMP7 expression, whereas DNMT1 overexpression suppressed BMP7. ChIP-qPCR verified DNMT1 binding to the BMP7 promoter CpG island, and qMSP confirmed that DNMT1 loss reduced BMP7 promoter methylation. Consistent with a pathogenic role, BMP7 knockdown alleviated hypoxia-induced right ventricular hypertrophy and vascular remodeling, while BMP7 supplementation exacerbated these phenotypes.

conclusionsOur study unveils the DNMT1-BMP7 axis as a critical epigenetic pathway in PH. Hypoxia-induced DNMT1 downregulation derepresses BMP7 via promoter hypomethylation, driving PASMCs proliferation and pathological vascular remodeling. Targeting this axis may offer novel therapeutic strategies for PH.

Indexed as

Bone Morphogenetic Protein 7DNA (Cytosine-5-)-Methyltransferase 1Epigenesis, GeneticHypertension, PulmonaryPulmonary ArteryUp-RegulationVascular RemodelingAnimalsCell ProliferationCells, CulturedHumansMaleMiceMice, Inbred C57BLMice, Knockoutbmp7 protein, mouseBone Morphogenetic Protein 7DNA (Cytosine-5-)-Methyltransferase 1Dnmt1 protein, mouseBone morphogenetic protein 7 (BMP7)DNA methyltransferase 1 (DNMT1)EpigeneticsPulmonary hypertension (PH)

Identifiers

PMID41402807
PMCPMC12910850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.